
Cadila Healthcare Limited has informed the Exchange regarding a press release dated July 30, 2021, titled " Zydus Cadila receives final approval from USFDA for Fulvestrant Injection".
Filed with NSE ·

Cadila Healthcare Limited has informed the Exchange regarding a press release dated July 30, 2021, titled " Zydus Cadila receives final approval from USFDA for Fulvestrant Injection".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences